There has been one death in a corona vaccine study in Brazil.
A subject in the clinical study from the pharmaceutical company AstraZeneca has died.
Rio - A participant in a series of tests at Oxford University for a vaccine against the coronavirus has died.
In the tests in Brazil, however, the man should
not have been given
the potential serum, but only a
placebo
, as Brazilian media reported on Wednesday.
The university said an independent expert review concluded there were
no safety issues
and testing could continue.
According to media reports, the deceased are a 28-year-old doctor who was active in the fight against the pandemic and who voluntarily participated in the tests for the vaccine.
The man was infected with the novel corona virus and died as a result of this infection.
In test series for new drugs or vaccines, it is common to give some of the participants not the agent to be tested, but only a placebo, to compare the effects.
A placebo is a bogus drug that does not contain any drug.
Oxford University is researching
an anti-corona vaccine
together with the British pharmaceutical company
AstraZeneca
.
The tests at Oxford University and AstraZeneca are in the third and final phase, which is very complex.
Thousands of people in several countries take part, in Brazil there are around 8,000 so far.
The drug, tested by Oxford University and AstraZeneca, is considered one of the most promising vaccine candidates worldwide.
Feverish research is being carried out around the world into vaccines against the new virus that controls large parts of the world.
In Germany, three pharmaceutical companies are working on a corona vaccine: CureVac, BioNTech and IDT Biologika *.
(AFP) * Merkur.de is part of the Ippen-Digital network
